Blood flow is a major influence on tumor cell metastasis

April 9, 2018, Cell Press
Blood flow is a major influence on tumor cell metastasis
This diagram shows the effect of blood flow on tumor metastasis. Credit: Jacky Goetz et al.

Scientists have long theorized that blood flow plays an integral role in cancer metastasis. But new research testing this long-held hypothesis in zebrafish and humans confirms that the circulatory blood flow impacts the position where circulating tumor cells ultimately arrest in the vasculature and exit into the body, where they can form a metastasis.

In a paper published April 9 in Developmental Cell, researchers from the French National Institute of Health and Medical Research (INSERM) found that in the model of the zebrafish embryo, labeled circulating (CTCs) could be followed throughout the . The location where the tumor arrested was found to be closely correlated with rates less than 400-600 μm/s. The larger aim of the study was to visualize the impact of blood flow on important steps in metastasis—arrest of the CTCs, adhesion to the vasculature, and extravasation of the CTCs from the blood vessel.

"A long-standing idea in the field is that arrest is triggered when circulating tumor cells end up in capillaries with a very small diameter simply because of size constraints," says author Jacky G. Goetz, PhD, whose laboratory conducted the study. "This research shows that this position is not only driven by physical constraint but that blood flow has a strong impact on allowing the tumor cells to establish adhesion with the vessel wall. I think this is an important addition to understanding how and where tumor cells would eventually form metastases."

Researchers chose the zebrafish embryo model since its vasculature is highly stereotyped. "This made it much easier to document the position of all the tumor cells after they were injected," explains Goetz. The team compiled all of the images together and created heat maps of the position of the tumor cells in the vasculature.

Blood flow tuning of tumor metastasis. Credit: Jacky Goetz

The researchers also found that blood flow is essential for the process of extravasation, when tumor cells leave the circulatory blood vessel and cross the endothelial barrier at a new site to establish a secondary tumor. "When we did timelapse imaging in the zebrafish embryo, we found that endothelial cells appear to curl around the tumor cells that are arrested in the blood vessel," says Goetz. "Blood flow at this step is essential. Without flow, endothelial remodeling does not occur. You need a certain amount of flow to keep the endothelium active so that it can remodel around the tumor cell."

They further confirmed this observation in in mice using intravital correlative microscopy, an imaging technique developed by the Goetz laboratory, in collaboration with Y.Schwab (EMBL, Heidelberg), which combines imaging living multicellular model systems with electron microscopy to provide details of dynamic or transient events in vivo.

The researchers next applied these findings to study brain metastases in 100 human patients from with heterogeneous primary locations. Similar to the zebrafish model, they mapped the position of the metastases and generated heatmaps. "We were able to merge the brain metastases map to a perfusion map of a control patient and found that it nicely reproduced exactly what we did in the zebrafish showing that metastases preferably develop in areas with low perfusion," says Goetz.

The researchers conclude that all of these findings show that blood at metastatic sites regulates where and how metastatic outgrowth develops. Looking ahead, the researchers plan on studying methods to inhibit the endothelial remodeling ability of the vessel to potentially impair extravasation and inhibit metastasis.

Explore further: Cancer metastasis: Cell polarity matters

More information: Developmental Cell, Follain G, et al: "Hemodynamic Forces Tune the Arrest, Adhesion, and Extravasation of Circulating Tumor Cells" http://www.cell.com/developmental-cell/fulltext/S1534-5807(18)30147-3 , DOI: 10.1016/j.devcel.2018.02.015

Related Stories

Cancer metastasis: Cell polarity matters

February 28, 2018
It's not only the number of migrating cancer cells that determines the risk for metastasis, but also their characteristics, scientists from the German Cancer Research Center (DKFZ) report in Nature Communications. For circulating ...

Metastatic lymph nodes can be the source of distant metastases in mouse models of cancer

March 22, 2018
A study by Massachusetts General Hospital (MGH) investigators finds that, in mouse models, cancer cells from metastatic lymph nodes can escape into the circulation by invading nodal blood vessels, leading to the development ...

Starving tumors: New target discovered

January 24, 2018
Actively growing tumors have a high demand for oxygen and nutrients. Therefore, they stimulate the growth of blood vessels through a process called angiogenesis. If tumor-associated angiogenesis is suppressed, it may limit ...

Watching tumors burst through a blood vessel

September 20, 2013
Cancer cells metastasize in several stages—first by invading surrounding tissue, then by infiltrating and spreading via the circulatory system. Some circulating cells work their way out of the vascular network, eventually ...

Researchers working on blood test to detect brain metastases while still treatable

August 4, 2017
Houston Methodist cancer researchers are now closer to creating a blood test that can identify breast cancer patients who are at increased risk for developing brain metastasis, and also monitor disease progression and response ...

Tumor blood vessel protein provides potential therapeutic target

August 27, 2014
Tumor blood vessels supply oxygen and nutrients to cancer cells and provide access to other organs. While tumor vasculature shares many features with normal vessels, their unique characteristics are potential therapeutic ...

Recommended for you

Potential seen for tailoring treatment for acute myeloid leukemia

December 8, 2018
Advances in rapid screening of leukemia cells for drug susceptibility and resistance are bringing scientists closer to patient-tailored treatment for acute myeloid leukemia (AML).

Study may offer doctors a more effective way to treat neuroblastoma

December 7, 2018
A very large team of researchers, mostly from multiple institutions across Germany, has found what might be a better way to treat patients with neuroblastoma, a type of cancer. In their paper published in the journal Science, ...

Inflammatory bowel disease linked to prostate cancer

December 7, 2018
Men with inflammatory bowel disease have four to five times higher risk of being diagnosed with prostate cancer, reports a 20-year study from Northwestern Medicine.

'Chemo brain' caused by malfunction in three types of brain cells, study finds

December 6, 2018
More than half of cancer survivors suffer from cognitive impairment from chemotherapy that lingers for months or years after the cancer is gone. In a new study explaining the cellular mechanisms behind this condition, scientists ...

Scientists develop new technology for profiling unique genetic makeup of myeloma tumor cells

December 6, 2018
Cancer arises when cells lose control. Deciphering the "blueprint" of cancer cells—outlining how cancer cells hijack specific pathways for uncontrolled proliferation—will lead to more efficient ways to fight it. Joint ...

Putting the brakes on tumor stealth

December 6, 2018
New research undertaken at Monash University has shed new light on how some cancers are able to escape our immune system.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.